GSK plunges as drugmaker must face Zantac cases in Delaware

GSK plunges as drugmaker must face Zantac cases in Delaware

Citi estimates Zantac settlement costs at US$3 billion GSK shares plunged in the wake of a court ruling that the UK drugmaker, alongside others including Sanofi, must face trials over whether the former heartburn treatment Zantac causes cancer. The ruling is a blow to GSK, paving the way for multiple trials in Delaware state…

Read More

Barrenjoey opens Abu Dhabi office as Australian bank expands

Barrenjoey opens Abu Dhabi office as Australian bank expands

Barrenjoey, an Australian investment bank, began offering fixed-income sales and trading services in Abu Dhabi in an expansion that marks the opening of its first overseas office. The move will allow the Sydney-based firm to provide extended coverage during European and US trading hours, it said in a statement. It currently has about 10 people…

Read More

Toyota halts sales of three cars as Japan safety scandal deepens

Toyota halts sales of three cars as Japan safety scandal deepens

Japan suspended the delivery and sales of six vehicles currently on the road, including three manufactured by Toyota Motor, escalating a safety scandal that’s embroiled some of the world’s top automakers.  Toyota submitted faulty data during pedestrian-safety tests for three current models – the Corolla Fielder, Corolla Axio and Yaris Cross –  and used modified…

Read More